Latest News
GMT Crypto Price Prediction: Will GMT Recover From the Chinese Ban?
Key points: The GMT crypto has sold off immensely from its all-time highs. The latest decline occurred after the banning of Chinese users.
Cineworld Shares Soared 18.7% on ‘Top Gun Maverick’ Debut – Is It a Buy?
Key points: Cineworld shares soared 18.7% after Top Gun Maverick’s debut on Friday. Investors cheered the movie’s excellent opening weekend perform
LUNA Crypto Price Prediction: Should You Buy the New LUNA Coin?
Key points: The LUNA crypto price has gotten off to a good start following its airdrop. Investors bought the new LUNA token despite its predecessor
Here’s Why Echo Energy (ECHO) Shares Surged 9.8% Today. Is It a Buy?
Key points: Echo Energy shares surged 9.76% on an upbeat Argentina operations update. The energy company increased its overall gas production at Ocea
Here’s Why Avacta Shares Are Rising Despite the Lack of News
Key points: Avacta shares are rising despite the lack of new releases from the firm. The shares are rallying due to the positive investor sentiment
Abingdon Health (ABDX) Shares Rallied on Deepverge Deal. What’s Next?
Key points: Abingdon Health shares surged 7% on the Deepverge LFT contract. The two firms will collaborate t develop lateral flow tests for Modern
Cornish Metals Shares, CUSN, Bubble 3% On Sleitat – Does It Actually Matter?
Key points: Cornish Metals has sold a 1% royalty in Sleitat Given that South Crofty is now funded this is not material In the long term it's the global tin price that ma
Oxford Metrics Shares, OMG, Leap 30% On Yotta Sale – Could It Go Further?
Key points: Oxford Metrics has sold Yotta to Causeway Cash receipts will be £52 million This allows the further development of Vicon, the core technology
Genedrive Shares, GDR, Up 9% On CTDA Approval – More To Come?
Key points: Genedrive has achieved a CDTA for its covid test This now allows sales - bulk and direct - in the UK What matters now is how many sales are actually generated
Here’s Why the 4D Pharma (DDDD) Shares Fell Despite Cancer Progress
Key points: 4d Pharma shares fell despite making progress in its cancer drugs. The biotech firm’s shares rose briefly before falling back down. Sour investor sentime
Jasmy Crypto Price Prediction: Will the IoT Token Ever Recover?
Key points: The Jasmy crypto price has fallen 86.2% YTD but is now trading sideways. The token could rally higher with the leading cryptos if the m
ProShares UltraShort ETF (SQQQ) Stock Price Is Falling. Is This the End?
Key points: The ProShares UltraPro Short QQQ ETF (SQQQ) stock price is falling. Does this mark the end of its recent rally? What should investors b
Cleveland Cliffs (CLF) Stock Fell 31% From Its April High. What’s Next?
Key points: Cleveland-Cliffs (CLF) stock has fallen 31% from its April high. However, the CLF stock looks like a buy at current prices.
The Xpeng (XPEV) Stock Price Has Fallen 56% YTD. Is the Firm a Buy?
Key points: The Xpeng stock price has fallen 56% in 2022. Should you buy it? The Chinese EV company has ambitious plans for the rest of 2022.
Iovance Biotherapuetics Stock Down 50% On Trial Data – Some You Lose
Key points: Iovance Biotherapeutics (NASDAQ: IOVA) stock is down 50% premarket It is suffering from trial data for its melanoma treatment The short interest in IOVA was so
Gap Stock, GPS, Drops 16% – The Fashion Brand That’s Out Of Fashion?
Key points: Gap announced results with a large EPS miss Guidance for full year revenues is also down Is Gap simply too out of fashion now?
Alien Metals (UFO) Shares Rallied on a Drilling Update. What’s Next?
Key points: Alien Metals shares edged higher after issuing its latest drilling update. The junior miner just started phase 4 RC drilling at its Han
First Group Shares – Why A 163.6p Bid Is Really Only 118p
Key points: First Group has received a conditional offer from I Squared This could be at 118p, could be 163p It depends upon the value we ascribe to the conditionality
Have Angle Shares, AGL, Topped Out After FDA Approval?
Key points: Angle shares have jumped 50% this week Parsortix, the cancer diagnosis by blood test, received FDA authorisation The question is whether this has further to g
Baidu (BIDU) Stock Surged Despite Reporting Q1 Losses. Is It a Buy?
Key points: The Baidu stock price surged despite a Q1 loss of $140 million. Lower revenues drove the loss amid lockdowns in China.